Nicotinamide Adenine Dinucleotide Market Size & Share 2022 to 2030
Market Size by Grade (Food grade, Pharmaceutical grade), by Application (Dietary supplements, Pharmaceuticals, Anti-aging Products) & Global Forecast.
Report ID: GMI5369
|
Published Date: September 2022
|
Report Format: PDF
Download Free PDF
Authors:
Kiran Pulidindi, Kunal Ahuja
Nicotinamide Adenine Dinucleotide Market Size
Nicotinamide Adenine Dinucleotide Market size was recorded at over USD 488 million in 2021. Driven by changing lifestyle choices, the industry is expected to grow at around 13% CAGR from 2022 to 2030.
Nicotinamide adenine dinucleotide or NAD is attaining positive attention due to its varied health benefits, such as improving athletic performance, reducing chronic fatigue syndrome, managing high cholesterol, treating depression, controlling high blood pressure, helping in anti-aging, maintaining the effects of alcohol on the liver, and more. Mounting utilization and demand from pharmaceuticals are likely to foster nicotinamide adenine dinucleotide market growth over 2022-2030.
Consistent R&D initiatives to improve the effectiveness of NADH or NAD+ on the metabolism to offer therapeutic intervention in inflammatory disorders are contributing substantially to the product adoption rate. For instance, a May 2022 study on NAD metabolism in the immune response, autoimmunity, and inflammageing, funded by the Spanish Ministry of Science and Innovation, concluded that stimuli timing, dosage, and the cellular metabolic state, together with the form of NAD+ supplementation result in the increased global level of NAD+.
Government regulations on dosage may restrain industry progression
Stringent government norms regarding dosage to prevent adverse health effects are foreseen to restrain industry expansion. As NAD works differently depending on the dosage and therapy, the government agencies of various countries have only given it OTC categorization. Nonetheless, advancements in food grade NAD in the form of immunity boosters are set to proliferate the demand for nicotinamide adenine dinucleotide supplements, thereby enabling companies to overcome this issue.
Nicotinamide Adenine Dinucleotide Market Analysis
In terms of grade, nicotinamide adenine dinucleotide market is categorized into food grade pharmaceutical grade, and others. The pharmaceutical grade is expected to surpass USD 515 million in revenue by 2030 as a result of numerous benefits of the product as an anti-depressant, an anti-aging solution, and for improving cell restoration, bolstering the inclusion of NADH in many disease-curing drugs, thereby stimulating the demand for the pharmaceutical grade of the nicotinamide adenine dinucleotide globally.
In terms of application, nicotinamide adenine dinucleotide market is segregated into dietary supplements, pharmaceuticals, anti-aging products, and others. Anti-aging products segment was valued at more than USD 110 million in 2021 and is estimated to progress at 14.5% CAGR over the next 8 years as NAD+ anti-aging products are used to treat rosacea, pigmentation, fine lines, wrinkles, and acne. The rising popularity of skincare and cosmetics products, along with the surging awareness of the advantages of NAD supplements.
Nicotinamide adenine dinucleotide market is segmented into Europe, Asia Pacific, North America, the Middle East & Africa, and Latin America. The Europe NAD market is anticipated to reach over USD 330 million in revenue by 2030. The surging consumer interest in anti-aging products containing nicotinamide adenine dinucleotide in is propelling regional market demand. In addition, the strong presence of pharmaceutical manufacturers that are providing advanced functional beverage products is speculated to augment the regional industry expansion.
Nicotinamide Adenine Dinucleotide Market Share
are some of the key nicotinamide adenine dinucleotide market players. These companies are adopting strategic mergers, collaborations, and acquisitions to expand their customer base and improve their product offerings.
Impact of COVID-19 Pandemic
The nicotinamide adenine dinucleotide industry witnessed an upsurge in demand during the COVID-19 pandemic as coronavirus resulted in the dysregulation of genes related to NAD+ metabolism. For instance, a 2022 study found that NAD+ and NMN supplements that were used to treat pneumonia phenotypes, consisting of hemolysis, excessive inflammatory cell infiltration, and embolization, in SARS-CoV-2-infected lungs were effectively liberated. Moreover, in the post-pandemic scenario, many companies are engaging in securing and sustaining their supply networks to fulfill the global demand for NAD, which is driving industry expansion in key regions worldwide.
The nicotinamide adenine dinucleotide market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in tons and revenue in USD Mn from 2017 to 2030 for the following segments:
Click here to Buy Section of this Report
By Grade
By Application
The above information is provided on a regional and country basis for the following:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →